Jim Cramer tackles Starbucks, the Federal Reserve, earnings and Mylan ahead of a week filled with potentially market-moving headlines.
Cancer diagnostics company Exact Sciences is in advanced talks to acquire Genomic Health for about $2.8 billion to strengthen its cancer-testing offerings, according to Bloomberg.
Shares of orthopedic device maker Zimmer Biomet jump after the company reports second-quarter earnings and sales that beat analysts' forecasts.
Shares of drugmaker AbbVie gain after the company posts better-than-expected quarterly earnings and raises its guidance for the remainder of the year.
Be zen and keep emotions out of investing decisions. It can pay off in higher portfolio returns.
The drugmaker reports second-quarter results that beat analysts' forecasts and raises its guidance for the remainder of the year on strong demand for its multiple sclerosis and other disease-fighting medications.
Stock drops as Pimavanserin study finds no statistically significant improvement in adult schizophrenia patients.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.